![APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | SpringerLink APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12072-021-10239-x/MediaObjects/12072_2021_10239_Fig1_HTML.png)
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | SpringerLink
![JPM | Free Full-Text | HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience JPM | Free Full-Text | HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience](https://www.mdpi.com/jpm/jpm-12-00285/article_deploy/html/images/jpm-12-00285-g001.png)
JPM | Free Full-Text | HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience
![Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations](https://f6publishing.blob.core.windows.net/32598b48-0f3d-46dd-8cdb-57f88f8eaa52/WJH-8-385-g001.jpg)
Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations
![Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy in: Journal of the National Comprehensive Cancer Network Volume 9 Issue 5 (2011) Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy in: Journal of the National Comprehensive Cancer Network Volume 9 Issue 5 (2011)](https://jnccn.org/view/journals/jnccn/9/5/0465fig02.jpeg)
Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy in: Journal of the National Comprehensive Cancer Network Volume 9 Issue 5 (2011)
![Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis | Scientific Reports Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-59406-4/MediaObjects/41598_2020_59406_Fig1_HTML.png)
Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis | Scientific Reports
![APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | SpringerLink APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12072-021-10239-x/MediaObjects/12072_2021_10239_Fig2_HTML.png)
APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | SpringerLink
![Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment - ScienceDirect Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1542356521006832-fx1.jpg)
Risk of Hepatitis B Virus Reactivation in Patients Treated With Immunotherapy for Anti-cancer Treatment - ScienceDirect
![Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy in: Journal of the National Comprehensive Cancer Network Volume 9 Issue 5 (2011) Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy in: Journal of the National Comprehensive Cancer Network Volume 9 Issue 5 (2011)](https://jnccn.org/view/journals/jnccn/9/5/0465fig01.jpeg)
Why, When, and How to Prevent Hepatitis B Virus Reactivation in Cancer Patients Undergoing Chemotherapy in: Journal of the National Comprehensive Cancer Network Volume 9 Issue 5 (2011)
![Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management](https://f6publishing.blob.core.windows.net/30b27806-8663-4883-8705-fc76a6916db9/WJH-10-352-g002.jpg)
Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management
![Definitions of HBV reactivation based on different society guidelines. | Download Scientific Diagram Definitions of HBV reactivation based on different society guidelines. | Download Scientific Diagram](https://www.researchgate.net/publication/350590739/figure/tbl2/AS:1019437540978689@1620064258576/Definitions-of-HBV-reactivation-based-on-different-society-guidelines.png)